 Prednisone
"Prednisone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
| Descriptor ID |
D011241
|
| MeSH Number(s) |
D04.808.745.432.719.702
|
| Concept/Terms |
Prednisone- Prednisone
- delta-Cortisone
- Dehydrocortisone
Cortan- Cortan
- Halsey Drug Brand of Prednisone
Cortancyl- Cortancyl
- Panafcort
- Aventis Brand of Prednisone
Cutason- Cutason
- mibe Brand of Prednisone
Decortin- Decortin
- Merck Brand of Prednisone
- Dacortin
Deltasone- Deltasone
- Pharmacia Brand of Prednisone
Meticorten- Meticorten
- Schering-Plough Brand of Prednisone
Orasone- Orasone
- Solvay Brand of Prednisone
Panasol- Panasol
- Seatrace Brand of Prednisone
Rectodelt- Rectodelt
- Trommsdorff Brand of Prednisone
Sone- Sone
- Fawns & McAllan Brand of Prednisone
Winpred- Winpred
- ICN Brand of Prednisone
|
Below are MeSH descriptors whose meaning is more general than "Prednisone".
Below are MeSH descriptors whose meaning is more specific than "Prednisone".
This graph shows the total number of publications written about "Prednisone" by people in UAMS Profiles by year, and whether "Prednisone" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 0 | 1 | 1 | | 2022 | 0 | 2 | 2 | | 2021 | 0 | 3 | 3 | | 2020 | 0 | 1 | 1 | | 2019 | 0 | 7 | 7 | | 2017 | 1 | 1 | 2 | | 2016 | 0 | 3 | 3 | | 2015 | 2 | 3 | 5 | | 2014 | 0 | 4 | 4 | | 2013 | 1 | 3 | 4 | | 2012 | 1 | 2 | 3 | | 2011 | 1 | 3 | 4 | | 2010 | 1 | 2 | 3 | | 2009 | 0 | 2 | 2 | | 2008 | 1 | 1 | 2 | | 2007 | 1 | 1 | 2 | | 2005 | 1 | 2 | 3 | | 2004 | 1 | 1 | 2 | | 2003 | 0 | 4 | 4 | | 1999 | 0 | 1 | 1 | | 1998 | 2 | 1 | 3 | | 1993 | 1 | 0 | 1 | | 1992 | 1 | 1 | 2 | | 1991 | 0 | 1 | 1 | | 1989 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Prednisone" by people in Profiles over the past ten years.
-
Zannat R, Lee J, Muzaffar J, Read ML, Brookes K, Sharma N, Boelaert K, McCabe CJ, Nieto HR. The potential interaction between medical treatment and radioiodine treatment success: A systematic review. Front Endocrinol (Lausanne). 2022; 13:1061555.
-
Draper E, Rollins B, Matlock S, Wong H, Shalin S. Milia en plaque manifesting as a post-herpetic isotopic response. Dermatol Online J. 2022 Jun 15; 28(3).
-
Elhusseiny AM, Sanders RN, Siddiqui MZ, Sallam AB. Non-arteritic Anterior Ischemic Optic Neuropathy with Macular Star following COVID-19 Vaccination. Ocul Immunol Inflamm. 2022 Jul; 30(5):1274-1277.
-
Mohan M, Meek JC, Meek ME, Broadwater R, Alapat D, van Rhee F. Combinatorial treatment for unresectable unicentric Castleman disease. Eur J Haematol. 2021 Oct; 107(4):484-488.
-
Sparano JA, Lee JY, Kaplan LD, Ramos JC, Ambinder RF, Wachsman W, Aboulafia D, Noy A, Henry DH, Ratner L, Cesarman E, Chadburn A, Mitsuyasu R. Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma. Haematologica. 2021 03 01; 106(3):730-735.
-
Fong JW, Chacko JG. Timing of cataract surgery in patients with giant cell arteritis. J Cataract Refract Surg. 2021 Jan 01; 47(1):83-86.
-
Ramos JC, Sparano JA, Chadburn A, Reid EG, Ambinder RF, Siegel ER, Moore PC, Rubinstein PG, Durand CM, Cesarman E, Aboulafia D, Baiocchi R, Ratner L, Kaplan L, Capoferri AA, Lee JY, Mitsuyasu R, Noy A. Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood. 2020 09 10; 136(11):1284-1297.
-
Bhutani M, Usmani SZ. Quadruplets come of age for newly diagnosed multiple myeloma. Lancet. 2020 01 11; 395(10218):94-96.
-
Guthrie J, King C, Battle L, Field H, Motwani P, Wong H, Kaley J, Shiver M, Gao L. Pyoderma gangrenosum developing after chest tube placement in a patient with chronic lymphocytic leukemia. Cutis. 2019 Nov; 104(5):E23-E26.
-
Bukhari A, El Chaer F, Koka R, Singh Z, Hutnick E, Ruehle K, Lee ST, Kocoglu MH, Shanholtz C, Badros A, Hardy N, Yared J, Rapoport AP, Dahiya S. Rapid relapse of large B-cell lymphoma after CD19 directed CAR-T-cell therapy due to CD-19 antigen loss. Am J Hematol. 2019 10; 94(10):E273-E275.
-
Boye B, Wayne M, Sukumaran S, Vijayan V. Blurry Vision and Irregularly Shaped Pupil in a 3-Year-Old Female. Clin Pediatr (Phila). 2019 08; 58(9):1038-1041.
-
van Rhee F, Stone K. Storming the Castle with TCP. Blood. 2019 04 18; 133(16):1697-1698.
-
Huang YH, Zhou DB, Han B, Li T, Wang SJ. Successful treatment of an adult with Kasabach-Merritt syndrome using thalidomide, vincristine, and prednisone. J Int Med Res. 2019 Apr; 47(4):1810-1814.
-
Zhang L, Zhao AL, Duan MH, Li ZY, Cao XX, Feng J, Zhou DB, Zhong DR, Fajgenbaum DC, Li J. Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease. Blood. 2019 04 18; 133(16):1720-1728.
-
Chatterjee K, Rochlani YM, Kuriakose K, Khasawneh K, Paydak H. Amiodarone Induced Interstitial and Organizing Pneumonia Reversed with Steroids. J Ark Med Soc. 2017 Jun; 113(12):294-296.
-
Bai S, Dormer N, Shoults C, Meyer A, Pierce CD, Neville KA, Kearns GL. Palatability of a novel oral formulation of prednisone in healthy young adults. J Pharm Pharmacol. 2017 Apr; 69(4):489-496.
-
Liu X, Deng T, Guo X, Guo Y, Wang L, Zhang J, Xia Z, Zhang Q, Xue K, Cao J, Shi J, Hong X. A retrospective analysis of outcomes for primary mediastinal large B-cell lymphoma treated with RCHOP followed by radiotherapy or front-line autologous stem cell transplantation. Hematology. 2017 Jun; 22(5):258-264.
-
Klair JS, Girotra M, Hutchins LF, Caradine KD, Aduli F, Garcia-Saenz-de-Sicilia M. Ipilimumab-Induced Gastrointestinal Toxicities: A Management Algorithm. Dig Dis Sci. 2016 07; 61(7):2132-9.
-
Paiva B, Corchete LA, Vidriales MB, Puig N, Maiso P, Rodriguez I, Alignani D, Burgos L, Sanchez ML, Barcena P, Echeveste MA, Hernandez MT, Garc?a-Sanz R, Ocio EM, Oriol A, Gironella M, Palomera L, De Arriba F, Gonzalez Y, Johnson SK, Epstein J, Barlogie B, Lahuerta JJ, Blade J, Orfao A, Mateos MV, San Miguel JF. Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance. Blood. 2016 Apr 14; 127(15):1896-906.
-
Usmani SZ, Cavenagh JD, Belch AR, Hulin C, Basu S, White D, Nooka A, Ervin-Haynes A, Yiu W, Nagarwala Y, Berger A, Pelligra CG, Guo S, Binder G, Gibson CJ, Facon T. Cost-effectiveness of lenalidomide plus dexamethasone vs. bortezomib plus melphalan and prednisone in transplant-ineligible U.S. patients with newly-diagnosed multiple myeloma. J Med Econ. 2016; 19(3):243-58.
-
Epeldegui M, Lee JY, Mart?nez AC, Widney DP, Magpantay LI, Regidor D, Mitsuyasu R, Sparano JA, Ambinder RF, Mart?nez-Maza O. Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-Related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 trial). Clin Cancer Res. 2016 Jan 15; 22(2):328-36.
-
Davies BW, Smith JM, Hink EM, Durairaj VD. C-Reactive Protein As a Marker for Initiating Steroid Treatment in Children With Orbital Cellulitis. Ophthalmic Plast Reconstr Surg. 2015 Sep-Oct; 31(5):364-8.
-
Li Z, Li F, Yi S, Gu Z, Yu Z, Xu Y, Feng X, Liu W, Zou D, Qi J, Zhan F, Qiu L. Superior efficacy of rituximab-based chemoimmunotherapy as an initial therapy in newly diagnosed patients with B cell indolent lymphomas: long-term results from a single center in China. BMC Cancer. 2015 Jul 29; 15:555.
-
Abdallah AO, Bansal M, Kemp SA, Schichman SA, Xiang Z. A unique presentation of unilateral pleural effusion in a patient with a high-grade plasma cell neoplasm. Leuk Lymphoma. 2015; 56(10):2989-91.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|